key: cord-0912336-1epb9vz3
authors: Bailly, Benoit; Péré, Helene; Veyer, David; Berceanu, Ana; Daguindau, Etienne; Roux, Pauline; Hermine, Olivier; de Lamballerie, Xavier; Bastard, Paul; Lacombe, Karine; Autran, Brigitte; Angelot Delettre, Fanny; Casanova, Jean Laurent; Imbeaud, Sandrine; Clairet, Anne Laure; Kroemer, Marie; Spehner, Laurie; Robillard, Nicolas; Puech, Julien; Marty-Quinternet, Solène; Lepiller, Quentin; Chirouze, Catherine; Bouiller, Kevin
title: Persistent COVID-19 in an immunocompromised host treated by SARS-CoV-2-specific monoclonal antibodies
date: 2021-10-01
journal: Clin Infect Dis
DOI: 10.1093/cid/ciab868
sha: c22e67c46a1a009a3cda173e2ac38ac1f2ef3e17
doc_id: 912336
cord_uid: 1epb9vz3

nan

A c c e p t e d M a n u s c r i p t 9 Figure 2 

Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience

M a n u s c r i p t 5 Acknowledgments: The authors thank the patients for his patience and determination to recover. Requests for data sharing should be e-mailed to the corresponding author.Conflict-of-interest disclosure: The authors declare no competing financial interests.A c c e p t e d M a n u s c r i p t 6